基蛋生物: 基蛋生物：关于取消监事会并修订《公司章程》的公告

Group 1 - The company plans to abolish the supervisory board and amend its Articles of Association to enhance governance structure and operational standards [1][2] - The supervisory functions will be transferred to the audit committee under the board of directors, in compliance with relevant laws and regulations [1][2] - The proposal to abolish the supervisory board will be submitted for approval at the shareholders' meeting [1] Group 2 - The company will revise the relevant clauses in its Articles of Association, including the definition of stakeholders to include employees [2][3] - The company is registered in Nanjing and operates under the unified social credit code [3][4] - The Articles of Association will serve as a legally binding document governing the rights and obligations between the company, shareholders, and management [6][11] Group 3 - The company’s business scope includes various technical services, medical device production, and sales [7][8] - The company’s shares are to be issued based on principles of fairness and equality, ensuring equal rights for all shareholders [17][18] - The company has specific provisions regarding the acquisition of its own shares, which require shareholder approval under certain conditions [24][25]